Alpa Laboratories Ltd. Announces Book Closure for 38th AGM on Sep 23-30, 2026
Alpa Laboratories Limited announced book closure from September 23 to September 30, 2026, for its 38th Annual General Meeting. The AGM is scheduled for September 30, 2026.
The announcement pertains to a standard corporate procedure (book closure for AGM) and does not involve any new financial information, strategic changes, or material business developments that would significantly impact the company.
The announcement is a routine corporate action regarding the book closure for an AGM and does not contain any information that would positively or negatively impact the company's financials or operations.
Alpa Laboratories Limited has announced the book closure dates pertaining to its 38th Annual General Meeting (AGM) for the Financial Year 2025-26. The AGM will be conducted via video conference on Wednesday, 30th September, 2026, at 14:00 PM. This is in compliance with directives from the Ministry of Corporate Affairs and SEBI.
The company's Register of Members and Share transfer book will be closed from Wednesday, 23rd September, 2026, to Wednesday, 30th September, 2026, inclusive. This closure is for the purpose of the upcoming AGM.
What to do with a filing like this
Alpa Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Alpa Laboratories Limited. Read the original for the full detail.